Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Global Allocation
  • Asset Class: Mixed Allocation
  • Geographic Focus: International

DWS Invest II - Global Bioinnovation

+ Add to Watchlist

DW2GBFC:LX

175.70 EUR 0.000.00%

As of 01:59:30 ET on 04/09/2015.

Snapshot for DWS Invest II - Global Bioinnovation (DW2GBFC)

Year To Date: - 3-Month: +16.30% 3-Year: - 52-Week Range: 108.00 - 182.52
1-Month: +1.93% 1-Year: +59.38% 5-Year: - Beta vs MXWO: 0.87

Mutual Fund Chart for DW2GBFC

No chart data available.
  • DW2GBFC:LX 175.70
  • 1M
  • 1Y
Interactive DW2GBFC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DW2GBFC

DWS Invest II - Global Bioinnovation is an open-end fund incorporated in Luxembourg. The Fund's objective is to seek capital appreciation. The Fund will invest at least 70% of its assets in shares, stock certificates, convertible bonds, convertible debentures and warrant-linked bonds whose underlying warrants are for securities, participation and dividend-right certificates.

Inception Date: 07-15-2013 Telephone: 352-42101-1 Tel
Managers: MARTIN BERBERICH / NOUSHIN IRANI TURNER
Web Site: www.dws.lu

Fundamentals for DW2GBFC

NAV (on 2015-04-09) 175.70
Assets (M) (on 2015-04-09) 5.00
Fund Leveraged N
Minimum Investment 400,000.00
Minimum Subsequent Investment 400,000.00

Dividends for DW2GBFC

No dividends reported

Fees & Expenses for DW2GBFC

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for DW2GBFC

Filing Date: 02/27/2015
Name Position Value % of Total
Biogen Inc 1,100 401,434 8.711%
Celgene Corp 2,850 312,222 6.775%
Gilead Sciences Inc 3,300 305,029 6.619%
iShares Nasdaq Biotechnology E 1,000 303,428 6.585%
BioMarin Pharmaceutical Inc 3,000 289,501 6.282%
CF Industries Holdings Inc 660 180,067 3.908%
Regeneron Pharmaceuticals Inc 440 164,519 3.570%
Alexion Pharmaceuticals Inc 866 140,748 3.054%
Pacira Pharmaceuticals Inc/DE 1,294 133,917 2.906%
Eurofins Scientific SE 550 133,430 2.896%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil